Two cases of carfilzomib ‐induced thrombotic microangiopathy successfully treated with Eculizumab in multiple myeloma
Treatment with proteasome inhibitors like carfilzomib in patients with multiple myeloma (MM) can induce thrombotic microangiopathy (TMA) characterized by neurological symptoms, acute kidney injury, hemolysis a...
Source: BMC Nephrology - Category: Urology & Nephrology Authors: Michael Rassner, Rebecca Baur, Ralph W äsch, Mario Schiffer, Johanna Schneider, Andreas Mackensen and Monika Engelhardt Tags: Case report Source Type: research